Nanomedicine Research Journal

Nanomedicine Research Journal

Nanomedicine Targeting Inflammatory Memory in Psoriasis: Mechanistic Rationale, Delivery Strategies, and Translational Challenges

Document Type : Original Research Article

Author
Medical Institute, RUDN University, Moscow, Russian Federation
Abstract
Psoriasis is a chronic inflammatory skin disease characterized by frequent relapse, even after successful clinical treatment. Increasing evidence suggests that persistent tissue-resident immune cells and inflammation-associated cellular memory contribute to disease recurrence, highlighting the limitations of conventional therapies focused primarily on cytokine suppression. Nanomedicine offers promising opportunities to overcome these limitations through targeted drug delivery, controlled release, and localized modulation of pathogenic immune responses. This review explores the mechanistic basis of inflammatory memory in psoriasis and examines emerging nanomedicine platforms, including lipid-based, polymeric, inorganic, and biomimetic carriers, as well as topical and microneedle-assisted delivery systems. Particular attention is given to preclinical strategies targeting tissue-resident memory T cells, inflammatory signaling pathways, and other cellular mechanisms involved in disease persistence. Despite encouraging experimental findings, clinical translation remains limited by uncertainties regarding long-term safety, target specificity, manufacturing reproducibility, and regulatory requirements. Future research should prioritize biomarker-guided approaches, mechanistic evaluation of immune memory modification, and well-designed clinical trials. Ultimately, nanomedicine may provide a promising foundation for advancing psoriasis treatment from temporary inflammatory suppression toward more durable disease remission and reduced recurrence.
Keywords
Subjects


Articles in Press, Accepted Manuscript
Available Online from 16 November 2026